Analysis of HCV quasispecies dynamic under selective pressure of combined therapy

Detalhes bibliográficos
Autor(a) principal: Jardim, Ana C. G.
Data de Publicação: 2013
Outros Autores: Bittar, Cintia, Matos, Renata P. A., Yamasaki, Lilian H. T., Silva, Rafael A. [UNIFESP], Pinho, Joao R. R., Fachini, Roberta M., Carareto, Claudia M. A., Mello, Isabel Maria Vicente Guedes de Carvalho [UNIFESP], Rahal, Paula
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/35898
http://dx.doi.org/10.1186/1471-2334-13-61
Resumo: Background: the quasispecies composition of Hepatitis C virus (HCV) could have important implications with regard to viral persistence and response to interferon-based therapy. the complete NS5A was analyzed to evaluate whether the composition of NS5A quasispecies of HCV 1a/1b is related to responsiveness to combined interferon pegylated (PEG-IFN) and ribavirin therapy.Methods: Viral RNA was isolated from serum samples collected before, during and after treatment from virological sustained responder (SVR), non-responder (NR) and the end-of-treatment responder patients (ETR). NS5A region was amplified, cloned and sequenced. Six hundred and ninety full-length NS5A sequences were analyzed.Results: This study provides evidence that lower nucleotide diversity of the NS5A region pre-therapy is associated with viral clearance. Analysis of samples of NRs and the ETRs time points showed that genetic diversity of populations tend to decrease over time. Post-therapy population of ETRs presented higher genetic distance from baseline probably due to the bottleneck phenomenon observed for those patients in the end of treatment. the viral effective population of those patients also showed a strong decrease after therapy. Otherwise, NRs demonstrated a continuous variation or stability of effective populations and genetic diversity over time that did not seem to be related to therapy. Phylogenetic relationships concerning complete NS5A sequences obtained from patients did not demonstrate clustering associated with specific response patterns. However, distinctive clustering of pre/post-therapy sequences was observed. in addition, the evolution of quasispecies over time was subjected to purifying or relaxed purifying selection. Codons 157 (P03), 182 and 440 (P42), 62 and 404 (P44) were found to be under positive selective pressure but it failed to be related to the therapy.Conclusion: These results confirm the hypothesis that a relationship exists between NS5A heterogeneity and response to therapy in patients infected with chronic hepatitis C.
id UFSP_91ac99943cccd7405c41a0c29e7876b4
oai_identifier_str oai:repositorio.unifesp.br:11600/35898
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Jardim, Ana C. G.Bittar, CintiaMatos, Renata P. A.Yamasaki, Lilian H. T.Silva, Rafael A. [UNIFESP]Pinho, Joao R. R.Fachini, Roberta M.Carareto, Claudia M. A.Mello, Isabel Maria Vicente Guedes de Carvalho [UNIFESP]Rahal, PaulaSão Paulo State UnivUniversidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)Sao Jose do Rio Preto Sch Med2016-01-24T14:31:09Z2016-01-24T14:31:09Z2013-02-01Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 16 p., 2013.1471-2334http://repositorio.unifesp.br/handle/11600/35898http://dx.doi.org/10.1186/1471-2334-13-61WOS000315901300001.pdf10.1186/1471-2334-13-61WOS:000315901300001Background: the quasispecies composition of Hepatitis C virus (HCV) could have important implications with regard to viral persistence and response to interferon-based therapy. the complete NS5A was analyzed to evaluate whether the composition of NS5A quasispecies of HCV 1a/1b is related to responsiveness to combined interferon pegylated (PEG-IFN) and ribavirin therapy.Methods: Viral RNA was isolated from serum samples collected before, during and after treatment from virological sustained responder (SVR), non-responder (NR) and the end-of-treatment responder patients (ETR). NS5A region was amplified, cloned and sequenced. Six hundred and ninety full-length NS5A sequences were analyzed.Results: This study provides evidence that lower nucleotide diversity of the NS5A region pre-therapy is associated with viral clearance. Analysis of samples of NRs and the ETRs time points showed that genetic diversity of populations tend to decrease over time. Post-therapy population of ETRs presented higher genetic distance from baseline probably due to the bottleneck phenomenon observed for those patients in the end of treatment. the viral effective population of those patients also showed a strong decrease after therapy. Otherwise, NRs demonstrated a continuous variation or stability of effective populations and genetic diversity over time that did not seem to be related to therapy. Phylogenetic relationships concerning complete NS5A sequences obtained from patients did not demonstrate clustering associated with specific response patterns. However, distinctive clustering of pre/post-therapy sequences was observed. in addition, the evolution of quasispecies over time was subjected to purifying or relaxed purifying selection. Codons 157 (P03), 182 and 440 (P42), 62 and 404 (P44) were found to be under positive selective pressure but it failed to be related to the therapy.Conclusion: These results confirm the hypothesis that a relationship exists between NS5A heterogeneity and response to therapy in patients infected with chronic hepatitis C.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)São Paulo State Univ, Dept Biol, Inst Biosci Language & Exact Sci, Sao Jose Do Rio Preto, SP, BrazilUniversidade Federal de São Paulo, Div Gastroenterol, Lab Appl Mol Hepatol, Hepatitis Sect, São Paulo, BrazilUniv São Paulo, Sch Med, Dept Gastroenterol, São Paulo Inst Trop Med, São Paulo, BrazilSao Jose do Rio Preto Sch Med, Dept Hepatol, São Paulo, BrazilUniversidade Federal de São Paulo, Div Gastroenterol, Lab Appl Mol Hepatol, Hepatitis Sect, São Paulo, BrazilFAPESP: 07/52073-0FAPESP: 06/60012-9Web of Science16engBiomed Central LtdBmc Infectious DiseasesAnalysis of HCV quasispecies dynamic under selective pressure of combined therapyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000315901300001.pdfapplication/pdf2209338${dspace.ui.url}/bitstream/11600/35898/1/WOS000315901300001.pdf3f5f2e96c3c32667efc642546b1df92cMD51open accessTEXTWOS000315901300001.pdf.txtWOS000315901300001.pdf.txtExtracted texttext/plain69726${dspace.ui.url}/bitstream/11600/35898/2/WOS000315901300001.pdf.txt87df0d937dbb4d3b630998aa7df7417bMD52open access11600/358982022-09-27 10:00:02.376open accessoai:repositorio.unifesp.br:11600/35898Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-09-27T13:00:02Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
title Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
spellingShingle Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
Jardim, Ana C. G.
title_short Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
title_full Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
title_fullStr Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
title_full_unstemmed Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
title_sort Analysis of HCV quasispecies dynamic under selective pressure of combined therapy
author Jardim, Ana C. G.
author_facet Jardim, Ana C. G.
Bittar, Cintia
Matos, Renata P. A.
Yamasaki, Lilian H. T.
Silva, Rafael A. [UNIFESP]
Pinho, Joao R. R.
Fachini, Roberta M.
Carareto, Claudia M. A.
Mello, Isabel Maria Vicente Guedes de Carvalho [UNIFESP]
Rahal, Paula
author_role author
author2 Bittar, Cintia
Matos, Renata P. A.
Yamasaki, Lilian H. T.
Silva, Rafael A. [UNIFESP]
Pinho, Joao R. R.
Fachini, Roberta M.
Carareto, Claudia M. A.
Mello, Isabel Maria Vicente Guedes de Carvalho [UNIFESP]
Rahal, Paula
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv São Paulo State Univ
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Sao Jose do Rio Preto Sch Med
dc.contributor.author.fl_str_mv Jardim, Ana C. G.
Bittar, Cintia
Matos, Renata P. A.
Yamasaki, Lilian H. T.
Silva, Rafael A. [UNIFESP]
Pinho, Joao R. R.
Fachini, Roberta M.
Carareto, Claudia M. A.
Mello, Isabel Maria Vicente Guedes de Carvalho [UNIFESP]
Rahal, Paula
description Background: the quasispecies composition of Hepatitis C virus (HCV) could have important implications with regard to viral persistence and response to interferon-based therapy. the complete NS5A was analyzed to evaluate whether the composition of NS5A quasispecies of HCV 1a/1b is related to responsiveness to combined interferon pegylated (PEG-IFN) and ribavirin therapy.Methods: Viral RNA was isolated from serum samples collected before, during and after treatment from virological sustained responder (SVR), non-responder (NR) and the end-of-treatment responder patients (ETR). NS5A region was amplified, cloned and sequenced. Six hundred and ninety full-length NS5A sequences were analyzed.Results: This study provides evidence that lower nucleotide diversity of the NS5A region pre-therapy is associated with viral clearance. Analysis of samples of NRs and the ETRs time points showed that genetic diversity of populations tend to decrease over time. Post-therapy population of ETRs presented higher genetic distance from baseline probably due to the bottleneck phenomenon observed for those patients in the end of treatment. the viral effective population of those patients also showed a strong decrease after therapy. Otherwise, NRs demonstrated a continuous variation or stability of effective populations and genetic diversity over time that did not seem to be related to therapy. Phylogenetic relationships concerning complete NS5A sequences obtained from patients did not demonstrate clustering associated with specific response patterns. However, distinctive clustering of pre/post-therapy sequences was observed. in addition, the evolution of quasispecies over time was subjected to purifying or relaxed purifying selection. Codons 157 (P03), 182 and 440 (P42), 62 and 404 (P44) were found to be under positive selective pressure but it failed to be related to the therapy.Conclusion: These results confirm the hypothesis that a relationship exists between NS5A heterogeneity and response to therapy in patients infected with chronic hepatitis C.
publishDate 2013
dc.date.issued.fl_str_mv 2013-02-01
dc.date.accessioned.fl_str_mv 2016-01-24T14:31:09Z
dc.date.available.fl_str_mv 2016-01-24T14:31:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 16 p., 2013.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/35898
http://dx.doi.org/10.1186/1471-2334-13-61
dc.identifier.issn.none.fl_str_mv 1471-2334
dc.identifier.file.none.fl_str_mv WOS000315901300001.pdf
dc.identifier.doi.none.fl_str_mv 10.1186/1471-2334-13-61
dc.identifier.wos.none.fl_str_mv WOS:000315901300001
identifier_str_mv Bmc Infectious Diseases. London: Biomed Central Ltd, v. 13, 16 p., 2013.
1471-2334
WOS000315901300001.pdf
10.1186/1471-2334-13-61
WOS:000315901300001
url http://repositorio.unifesp.br/handle/11600/35898
http://dx.doi.org/10.1186/1471-2334-13-61
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Bmc Infectious Diseases
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 16
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/35898/1/WOS000315901300001.pdf
${dspace.ui.url}/bitstream/11600/35898/2/WOS000315901300001.pdf.txt
bitstream.checksum.fl_str_mv 3f5f2e96c3c32667efc642546b1df92c
87df0d937dbb4d3b630998aa7df7417b
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764166168051712